Amidst R&D reshuf­fle, Ver­tex ex­pands its pres­ence in Boston, aim­ing to be­come num­ber one

Ver­tex Phar­ma­ceu­ti­cals has been one of the buzzi­er names in the bustling Boston biotech scene, but now the com­pa­ny is look­ing to vault to num­ber one sta­tus — at least in terms of phys­i­cal foot­print.

At a rib­bon cut­ting on Tues­day for its new Jef­frey Lei­den Cen­ter for Cell and Ge­net­ic Ther­a­pies at the Boston Sea­port, Ver­tex an­nounced it would em­bark on a new project: The com­pa­ny will build a 344,000 square foot fa­cil­i­ty in the sea­port to ac­com­mo­date the com­pa­ny’s grow­ing R&D needs, es­pe­cial­ly in its cell and gene ther­a­pies pro­gram.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER